Literature DB >> 10863642

In situ diagnosis of human papillomaviruses.

E R Unger1.   

Abstract

In situ hybridization (ISH) is the demonstration of specific genetic information within a morphologic context. For HPV, colorimetric ISH has the advantage that it can be applied to routine formalin-fixed paraffin embedded tissues. This conserves patient material and permits histologic selection of optimal material for testing. ISH allows for precise spatial localization of viral sequences within tissues. ISH also allows the integration status of HPV to be determined. The major limitations of the method are the potential for error in HPV typing because of probe cross-hybridization and relatively low sensitivity if the method is not fully optimized.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10863642

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  4 in total

1.  DNA microarray format for detection and subtyping of human papillomavirus.

Authors:  Corné H W Klaassen; Clemens F M Prinsen; Hanneke A de Valk; Alphons M Horrevorts; Marcel A F Jeunink; Frederik B J M Thunnissen
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

2.  Sentinel-base DNA genotyping using multiple sequencing primers for high-risk human papillomaviruses.

Authors:  Baback Gharizadeh; Biying Zheng; Michael Akhras; Mehran Ghaderi; Olufisayo Jejelowo; Björn Strander; Pål Nyrén; Keng-Ling Wallin; Nader Pourmand
Journal:  Mol Cell Probes       Date:  2006-03-03       Impact factor: 2.365

3.  Human papillomavirus genotyping by multiplex pyrosequencing in cervical cancer patients from India.

Authors:  Cheryl M Travasso; Mona Anand; Mansi Samarth; Aditi Deshpande; Chandan Kumar-Sinha
Journal:  J Biosci       Date:  2008-03       Impact factor: 1.826

4.  A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.

Authors:  Nicolas F Schlecht; Margaret Brandwein-Gensler; Gerard J Nuovo; Maomi Li; Anne Dunne; Nicole Kawachi; Richard V Smith; Robert D Burk; Michael B Prystowsky
Journal:  Mod Pathol       Date:  2011-05-13       Impact factor: 7.842

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.